Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-20-005185

Options or other derivatives

  • Chief Financial Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Wells David R. Chief Financial Officer 2020-01-25 Grant or award · Stock Options +20,000 20,000 D
Loading xslF345X03/doc4.xml…